CAS: 2135696-72-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tarlox-TKI REF: 3D-KKD69672CAS: 2135696-72-7 | Min. 95% | To inquire | Mon 13 Jan 25 |
 | Tarlox-TKI REF: TM-T11761CAS: 2135696-72-7 | 97.03% | To inquire | Tue 21 Jan 25 |
Tarlox-TKI
CAS:2135696-72-7
Tarlox-TKI is a drug with potential anti-cancer activity, which acts as a selective inhibitor of …
Formula:
C19H18BrClN6O
Purity:
Min. 95%
Molecular weight:
461.7 g/mol
Ref: 3D-KKD69672
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
Tarlox-TKI
CAS:2135696-72-7
Tarlox-TKI (Kinase inhibitor-1) is a pan-ErbB inhibitor, the active ingredient of Tarloxotinib, which has antitumor …
Formula:
C19H18BrClN6O
Purity:
97.03%
Color and Shape:
Solid
Molecular weight:
461.74
Ref: TM-T11761
| 1mg | 142.00 € | ||
| 1mL*10mM (DMSO) | 253.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
